Pimavanserin

Psilocybin Therapy for Depression in Parkinson's Disease

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Psilocybin Efficacy With or Without Pimavanserin Pretreatment

Pimavanserin for Insomnia in Veterans With PTSD

Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

Comparing Antipsychotic Medications in LBD Over Time

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia

Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Pimavanserin for Sleep in Parkinson Disease

Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept

Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine